ATE270268T1 - 2,4-diamino-3-hydroxycarboxylsäurederivate als proteasome inhibitoren - Google Patents

2,4-diamino-3-hydroxycarboxylsäurederivate als proteasome inhibitoren

Info

Publication number
ATE270268T1
ATE270268T1 AT00927038T AT00927038T ATE270268T1 AT E270268 T1 ATE270268 T1 AT E270268T1 AT 00927038 T AT00927038 T AT 00927038T AT 00927038 T AT00927038 T AT 00927038T AT E270268 T1 ATE270268 T1 AT E270268T1
Authority
AT
Austria
Prior art keywords
substituted
alkyl
unsubstituted
arylalkyl
formula
Prior art date
Application number
AT00927038T
Other languages
English (en)
Inventor
Dennis France
Peter Fuerst
Johann Zimmermann
Carlos Garcia-Echeverria
Dieter Scholz
Pascal Furet
Patricia Imbach
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE270268T1 publication Critical patent/ATE270268T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
AT00927038T 1999-04-27 2000-04-25 2,4-diamino-3-hydroxycarboxylsäurederivate als proteasome inhibitoren ATE270268T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30077999A 1999-04-27 1999-04-27
US38870099A 1999-09-02 1999-09-02
PCT/EP2000/003688 WO2000064863A1 (en) 1999-04-27 2000-04-25 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors

Publications (1)

Publication Number Publication Date
ATE270268T1 true ATE270268T1 (de) 2004-07-15

Family

ID=26971977

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00927038T ATE270268T1 (de) 1999-04-27 2000-04-25 2,4-diamino-3-hydroxycarboxylsäurederivate als proteasome inhibitoren

Country Status (13)

Country Link
US (1) US20050026994A1 (de)
EP (1) EP1173413B1 (de)
JP (1) JP2002543058A (de)
CN (1) CN100357267C (de)
AT (1) ATE270268T1 (de)
AU (1) AU4555800A (de)
BR (1) BR0010134A (de)
CA (1) CA2370830C (de)
DE (1) DE60011889T2 (de)
ES (1) ES2223512T3 (de)
HK (1) HK1044931A1 (de)
PT (1) PT1173413E (de)
WO (1) WO2000064863A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU49055B (sh) 1996-04-25 2003-08-29 Milenko dipl.ing. Pupović Sto za nameštanje kičme
GB0012795D0 (en) * 2000-05-25 2000-07-19 Novartis Ag Organic compounds
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
CN1509462A (zh) 2001-05-21 2004-06-30 NF-κB抑制剂在治疗干眼疾病中的用途
PT1392355E (pt) 2001-05-21 2007-03-30 Alcon Inc Utilização de inibidores do proteassoma para tratar distúrbios associados à secura ocular
US7112588B2 (en) 2001-05-21 2006-09-26 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
US6645994B1 (en) 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
US7576206B2 (en) 2003-08-14 2009-08-18 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7223745B2 (en) 2003-08-14 2007-05-29 Cephalon, Inc. Proteasome inhibitors and methods of using the same
EP1637529A1 (de) 2004-09-20 2006-03-22 4Sc Ag Neue Piperidin-4-yl-Thiazol-Carboxamid-Analog als Inhibitoren für die Vermehrung von T-Zellen und ihre Verwendung
US7468383B2 (en) 2005-02-11 2008-12-23 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US8459852B2 (en) 2007-10-05 2013-06-11 Dental Equipment, Llc LED-based dental exam lamp
CA2785300A1 (en) 2009-12-22 2011-07-21 Cephalon, Inc. Proteasome inhibitors and processes for their preparation, purification and use
WO2018143145A1 (ja) * 2017-01-31 2018-08-09 中外製薬株式会社 無細胞翻訳系におけるペプチドの合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5344634A (en) * 1976-10-01 1978-04-21 Kyowa Hakko Kogyo Co Ltd Carcinostatic agent
MX9203836A (es) * 1991-07-02 1993-01-01 Sandoz Ag Derivados de acido-4-amino-3-hidroxicarboxilico y proceso para su preparacion.
US5538997A (en) * 1993-03-12 1996-07-23 Sandoz Ltd. 2,4-diamino-3-hydroxycarboxylic acid derivatives
DE4331135A1 (de) * 1993-09-14 1995-03-16 Bayer Ag Neue antiviral wirksame valinhaltige Pseudopeptide

Also Published As

Publication number Publication date
DE60011889T2 (de) 2005-07-14
EP1173413A1 (de) 2002-01-23
CN100357267C (zh) 2007-12-26
DE60011889D1 (en) 2004-08-05
HK1044931A1 (en) 2002-11-08
EP1173413B1 (de) 2004-06-30
BR0010134A (pt) 2002-01-15
JP2002543058A (ja) 2002-12-17
AU4555800A (en) 2000-11-10
CN1351587A (zh) 2002-05-29
CA2370830A1 (en) 2000-11-02
PT1173413E (pt) 2004-10-29
ES2223512T3 (es) 2005-03-01
WO2000064863A1 (en) 2000-11-02
US20050026994A1 (en) 2005-02-03
CA2370830C (en) 2009-10-13

Similar Documents

Publication Publication Date Title
ATE270268T1 (de) 2,4-diamino-3-hydroxycarboxylsäurederivate als proteasome inhibitoren
NO882036L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske ketoner.
ATE396988T1 (de) Chinolin- und chianzolinderivate zur behandlung von tumoren
HUP0303146A2 (hu) Protein kináz gátló hatású 3-(4-amido-pirrol-2-il-metilidén)-2-indolinon származékok és ezeket tartalmazó gyógyszerkészítmények
HUP0203228A2 (hu) Szubsztituált indolszármazékok az NFKB-aktivitás módosítására, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
HUP0400710A2 (hu) Tioéter helyettesítővel helyettesített imidazokinolinszármazékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
DE69529614T2 (de) Heterobizyklische derivate
HUP0105414A2 (hu) Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
RU2003116648A (ru) Замещенные имидазопиридины
HUP0203142A2 (hu) Benzodiazepinszármazékok, eljárás a vegyületek előállítására, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE69316067T2 (de) Arzneimittel zur Verwendung bei der Behandlung von Parkinsonismus
FI945538A0 (fi) 7-(2-Aminoetyyli)-bentsotiatsolonit
JP2005538111A5 (de)
FR2800735B1 (fr) Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation
RU2006130865A (ru) Производные пирролопиримидина, применяемые для лечения пролиферативных заболеваний
ES2106439T3 (es) 5-(piperazinilalquil)-1,5-benzotiazepinonas utiles como antagonistas de calcio.
DE69315363D1 (de) Amphotere tricyclische Verbindungen als antihistaminische und antiallergische Mittel
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
ATE311182T1 (de) Benzopyranderivate zur behandlung von perihperer gefässerkrankung
TH58670B (th) อนุพันธ์ 2-อะมิโน-3-(แอลคิล)-พิริมิโดน

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1173413

Country of ref document: EP

REN Ceased due to non-payment of the annual fee